• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail
?
-

Resources for You

OCTGT Learn

Welcome to OCTGT Learn, the Center for Biologics, Evaluation and Research's (CBER) Office of Cellular, Tissue and Gene Therapies (OCTGT) web page for industry education. CBER ensures the safety, purity, potency, and effectiveness of biological products, including vaccines and allergenics, blood and blood products, and cells, tissues, and gene therapies for the prevention, diagnosis, and treatment of human diseases, conditions, or injuries.  OCTGT-regulated products include gene therapy, tumor vaccines, xenotransplantation, stem cells, human tissue for transplantation, combination products, bioengineered tissues and certain medical devices.

Disclosure:
The presenters are OCTGT staff and therefore, as employees, have claimed no interests, financial or otherwise, with products that may be shown in any of the presentations.

OCTGT Learn Course List:
Listed below are the courses OCTGT currently offers. Additional online courses may be developed and will be posted upon completion.

You may submit suggestions for future courses to OCTGTLearn@fda.hhs.gov.

-

Course List

-